Viatris Announces Approval of First Generic Iron Sucrose Injection in the U.S.
August 11, 2025
Approval is Another Milestone of Viatris’ Ability to Successfully Develop Complex Generic Medicines Viatris Inc., a global healthcare company listed on Nasdaq as VTRS, announced